Avera Oahe Manor in Gettysburg, SD

Avera Oahe Manor is a medicaid certified nursing home in Gettysburg, South Dakota. It is located in Potter county at 700 E Garfield, Gettysburg, South Dakota 57442. You can reach out to the office of Avera Oahe Manor via phone at (605) 765-2461. This skilled nursing facility has 53 federally certified beds with average occupancy rate of 67.74%. Its legal business name is Legal Business Name Not Available and has the following ownership type - Non Profit - Church Related.

Avera Oahe Manor (Medicare CCN 43A113) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicaid program. This means if you are part of medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1991 (33 years certified) and the last quality survey was conducted in April, 2019.

Name	Avera Oahe Manor
Location	700 E Garfield, Gettysburg, South Dakota
Certified By	Medicaid
No. of Certified Beds	53
Occupancy Rate	67.74%
Medicare ID (CCN)	43A113
Legal Business Name	Legal Business Name Not Available
Ownership Type	Non Profit - Church Related

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Avera Oahe Manor from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Avera Oahe Manor are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Avera Oahe Manor give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Researchers to find better ways to manage chronic pain by treating neuroinflammation

Thanks to a two year, $974,024 NIH-funded ARRA (American Recovery and Reinvestment Act) grant, Saint Louis University and Southern Illinois University Edwardsville researchers are working to find better ways to manage chronic pain by treating neuroinflammation.

GTx to continue two pivotal Phase III clinical trials of enobosarm

GTx, Inc. today announced that a per protocol safety review of unblinded safety data on Friday April 12, 2013, by an independent Data Safety Monitoring Board, resulted in a determination that GTx continue as planned its two pivotal Phase III clinical trials of enobosarm (GTx-024) for the prevention and treatment of muscle wasting in patients with advanced non-small cell lung cancer.

AED Vimpat to be the subject of numerous studies and analyses at AAN meeting

The antiepileptic drug Vimpat- (lacosamide) (C-V) will be the subject of numerous studies and analyses-both UCB-sponsored and independent-at the 62nd annual American Academy of Neurology meeting, taking place at the Metro Toronto Convention Centre in Toronto from April 10-17.

Yellow fever outbreak in howler monkeys signals the need for human vaccination program

A group of Argentine scientists, including health experts from the Wildlife Conservation Society, have announced that yellow fever is the culprit in a 2007-2008 die-off of howler monkeys in northeastern Argentina, a finding that underscores the importance of paying attention to the health of wildlife and how the health of people and wild nature are so closely linked.

A*STAR's SIgN discovers new strategy to develop universal dengue vaccine

A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network. This breakthrough strategy opens a door of hope to what may become the world's first universal dengue vaccine candidate that can give full protection from all four serotypes of the dreadful virus.

Read more Medical News

› Verified 6 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Avera Oahe Manor is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.
Percentage of long-stay residents whose need for help with daily activities has increased	21.43	14.46
Percentage of long-stay residents who lose too much weight	3.65	5.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder	50	48.41
Percentage of long-stay residents with a catheter inserted and left in their bladder	4.18	1.79
Percentage of long-stay residents with a urinary tract infection	1.38	2.65
Percentage of long-stay residents who have depressive symptoms	0	5.05
Percentage of long-stay residents who were physically restrained	0	0.23
Percentage of long-stay residents experiencing one or more falls with major injury	11.72	3.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine	78.62	93.87
Percentage of long-stay residents who received an antipsychotic medication	13.67	14.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine	54.55	83.88